CWM
TMDX icon

Clearview Wealth Management’s Transmedics TMDX Stock Holding History

Clearview Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,326
Closed -$231K – 63
2026
Q1 		$231K Buy
+2,326
New +$303K 0.16% 53

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Clearview Wealth Management's TMDX Position: Q2 2026 in Review

Clearview Wealth Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,326 shares — an estimated $231K sold.

Clearview Wealth Management first reported a position in TMDX in Q1 2026 and held it in 1 quarter. The position peaked at $231K in Q1 2026. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Clearview Wealth Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Clearview Wealth Management sold 2,326 Transmedics shares in Q2 2026, an estimated $231K.
  • Clearview Wealth Management first reported a position in Transmedics in Q1 2026 and held it in 1 quarter.
  • Clearview Wealth Management's Transmedics position peaked at $231K in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Clearview Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.